These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27830574)

  • 1. Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.
    Haroon E; Miller AH
    Curr Top Behav Neurosci; 2017; 31():173-198. PubMed ID: 27830574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
    Haroon E; Fleischer CC; Felger JC; Chen X; Woolwine BJ; Patel T; Hu XP; Miller AH
    Mol Psychiatry; 2016 Oct; 21(10):1351-7. PubMed ID: 26754953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
    Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
    Neuropsychopharmacology; 2014 Jun; 39(7):1777-85. PubMed ID: 24481242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
    Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
    Brain Behav Immun; 2015 May; 46():17-22. PubMed ID: 25500218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.
    Haroon E; Chen X; Li Z; Patel T; Woolwine BJ; Hu XP; Felger JC; Miller AH
    Transl Psychiatry; 2018 Sep; 8(1):189. PubMed ID: 30202011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study.
    Taylor MJ; Godlewska B; Near J; Christmas D; Potokar J; Collier J; Klenerman P; Barnes E; Cowen PJ
    Psychol Med; 2014 Mar; 44(4):789-95. PubMed ID: 23659574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, glutamate, and glia in depression: a literature review.
    McNally L; Bhagwagar Z; Hannestad J
    CNS Spectr; 2008 Jun; 13(6):501-10. PubMed ID: 18567974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
    Lally N; Nugent AC; Luckenbaugh DA; Ameli R; Roiser JP; Zarate CA
    Transl Psychiatry; 2014 Oct; 4(10):e469. PubMed ID: 25313512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
    McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
    Abdallah CG; Sanacora G; Duman RS; Krystal JH
    Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.
    Felger JC
    Curr Top Behav Neurosci; 2017; 31():199-219. PubMed ID: 27225499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla.
    Godlewska BR; Masaki C; Sharpley AL; Cowen PJ; Emir UE
    Psychol Med; 2018 Jul; 48(10):1731-1737. PubMed ID: 29224573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
    Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.
    Felger JC
    Curr Neuropharmacol; 2018; 16(5):533-558. PubMed ID: 29173175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats.
    Perrine SA; Ghoddoussi F; Michaels MS; Sheikh IS; McKelvey G; Galloway MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():9-15. PubMed ID: 24246571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
    Paslakis G; Gass P; Deuschle M
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New paradigms for treatment-resistant depression.
    Zarate C; Duman RS; Liu G; Sartori S; Quiroz J; Murck H
    Ann N Y Acad Sci; 2013 Jul; 1292():21-31. PubMed ID: 23876043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.